October 28, 2016 12:12 PM ET


Company Overview of Rempex Pharmaceuticals, Inc.

Company Overview

As of December 3, 2013 Rempex Pharmaceuticals, Inc. has been acquired by The Medicines Company. Rempex Pharmaceuticals, Inc. discovers and develops antibacterial drugs. The company offers Minocin IV, a Minocycline for injection to wholesale pharmaceutical distributors in the United States. It is also developing RPX-602, a reformulation of Minocin IV; and Carbavance, an investigational agent that is a combination of a beta-lactamase inhibitor with a carbapenem. The company was founded in 2011 and is based in San Diego, California.

11535 Sorrento Valley Road

San Diego, CA 92121

United States

Founded in 2011





Key Executives for Rempex Pharmaceuticals, Inc.

Rempex Pharmaceuticals, Inc. does not have any Key Executives recorded.

Rempex Pharmaceuticals, Inc. Key Developments

Rempex Pharmaceuticals Wins Contract from Biomedical Advanced Research and Development Authority

Rempex Pharmaceuticals has been awarded the next option on a contract by the Biomedical Advanced Research and Development Authority to support the development of CARBAVANCE. CARBAVANCE is the combination of a carbapenem antibiotic with a novel beta-lactamase inhibitor that is targeted for treatment of multi-drug resistant gram-negative infections, including those due to carbapenem-resistant Enterobacteriaceae.

Rempex Pharmaceuticals, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-26-2015 02:30 PM

Rempex Pharmaceuticals, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-26-2015 02:30 PM. Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Daniel D. Burgess, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rempex Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.